0001654954-26-003760
SEC filingBlackRock, Inc. disclosed an increase in its total voting rights stake in Rentokil Initial plc to 13.00% as of 17 April 2026, comprising 10.44% in shares and 2.56% through financial instruments, triggering a regulatory notification under UK disclosure rules.
This filing is a mandatory TR-1 notification under UK Disclosure and Transparency Rules (DTR), triggered when a person’s holding of voting rights in a UK-listed company crosses or reaches certain thresholds (e.g., 3%, 5%, 10%, 15%). BlackRock, Inc. reported its aggregate stake in Rentokil Initial plc reached 13.00% on 17 April 2026 — up from 12.51% in the prior notification — driven by increases across both share-based and instrument-based holdings. The 10.44% shareholding reflects indirect ownership through multiple layered subsidiaries across jurisdictions (U.S., U.K., Singapore, Netherlands, Australia, Canada, Japan, Mexico, etc.), consistent with BlackRock’s global custody and investment management structure. The 2.56% attributable to financial instruments includes economically equivalent exposures such as ADRs (2.36%), which represent underlying ordinary shares, and derivative positions (CFDs and ELNs) that confer economic exposure without direct title. While this does not indicate a change in control or activist intent, it signals heightened institutional interest and may influence market perception of Rentokil’s governance profile and shareholder base stability. No voting agreements, proxy arrangements, or intentions regarding further acquisition or disposal are disclosed.